Approval of Parkinson’s therapy urged in Europe under brand name Hopledo
A European Medicines Agency (EMA) committee is recommending approval of Hopledo (IPX203) — an extended-release formulation of levodopa and carbidopa sold in the U.S. under the brand name Crexont — for…